Oncocyte Corp Stock Today
| OCX Stock | USD 2.69 0.14 4.95% |
Performance0 of 100
| Odds Of DistressLess than 40
|
OncoCyte Corp is trading at 2.69 as of the 30th of May 2024; that is -4.95 percent down since the beginning of the trading day. The stock's open price was 2.83. OncoCyte Corp has about a 40 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for OncoCyte Corp are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of March 2024 and ending today, the 30th of May 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 4th of January 2016 | Category Healthcare | Classification Health Care |
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. OncoCyte Corporation was incorporated in 2009 and is based in Irvine, California. The company has 13.36 M outstanding shares of which 349.73 K shares are now shorted by investors with about 9.16 days to cover. More on OncoCyte Corp
Moving together with OncoCyte Stock
| 0.61 | EGRX | Eagle Pharmaceuticals | PairCorr |
| 0.77 | JNJ | Johnson Johnson Financial Report 18th of July 2024 | PairCorr |
Moving against OncoCyte Stock
| 0.63 | ITCI | Intracellular Th | PairCorr |
| 0.62 | BSGM | Biosig Technologies | PairCorr |
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
OncoCyte Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. OncoCyte Corp's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding OncoCyte Corp or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary, OncoCyte Corp's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to OncoCyte Corp's managers, analysts, and investors.
Environmental | Governance | Social |
| CEO | Michael West | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering OncoCyte Corp report their recommendations after researching OncoCyte Corp's financial statements, talking to executives and customers, or listening in on OncoCyte Corp's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering OncoCyte Corp. The OncoCyte consensus assessment is calculated by taking the average forecast from all of the analysts covering OncoCyte Corp. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the analysis of OncoCyte Corp's profitability, liquidity, and operating efficiency, OncoCyte Corp is not in a good financial situation at this time. It has a very high odds of going through financial crisis in June. Financial strength of OncoCyte Corp is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
OncoCyte Corp's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to OncoCyte Corp's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand OncoCyte Corp's financial leverage. It provides some insight into what part of OncoCyte Corp's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
OncoCyte Corp (OCX) is traded on NASDAQ Exchange in USA. It is located in 15 Cushing, Irvine, CA, United States, 92618 and employs 43 people. OncoCyte Corp is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a total capitalization of 35.02 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate OncoCyte Corp's market, we take the total number of its shares issued and multiply it by OncoCyte Corp's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. OncoCyte Corp runs under Biotechnology sector within Health Care industry. The entity has 13.36 M outstanding shares of which 349.73 K shares are now shorted by investors with about 9.16 days to cover.
OncoCyte Corp has about 45.41 M in cash with (23.32 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.38.
Check OncoCyte Corp Probability Of Bankruptcy
Ownership AllocationThe market capitalization of OncoCyte Corp is $35.02 Million. Over half of OncoCyte Corp's outstanding shares are owned by third-party entities. These third-party entities are typically referred to as corporate investors that secure positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in OncoCyte Corp. Please watch out for any change in the institutional holdings of OncoCyte Corp as this could mean something significant has changed or is about to change at the company. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check OncoCyte Ownership Details
OncoCyte Stock Institutional Holders
Institutional Holdings refers to the ownership stake in OncoCyte Corp that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of OncoCyte Corp's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing OncoCyte Corp's value.| Instituion | Recorded On | Shares | |
| Ubs Group Ag | 2023-12-31 | 1.4 K | |
| Royal Bank Of Canada | 2023-12-31 | 901 | |
| Pnc Financial Services Group Inc | 2023-12-31 | 500 | |
| Bank Of America Corp | 2023-12-31 | 216 | |
| Jpmorgan Chase & Co | 2023-12-31 | 154 | |
| Nbc Securities Inc | 2024-03-31 | 150 | |
| Advisor Group Holdings, Inc. | 2023-12-31 | 97.0 | |
| Rhumbline Advisers | 2023-12-31 | 66.0 | |
| Wells Fargo & Co | 2023-12-31 | 60.0 | |
| Broadwood Capital Inc | 2024-03-31 | 2.5 M | |
| Awm Investment Company Inc | 2023-12-31 | 754.3 K |
OncoCyte Corp Historical Income Statement
OncoCyte Corp Income Statement is one of the three primary financial statements used for reporting OncoCyte's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of OncoCyte Corp revenue and expense. OncoCyte Corp Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, OncoCyte Corp's Interest Expense is fairly stable compared to the past year. Gross Profit is likely to rise to about 526 K in 2024, whereas Depreciation And Amortization is likely to drop slightly above 1.6 M in 2024. View More FundamentalsOncoCyte Stock Against Markets
Picking the right benchmark for OncoCyte Corp stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in OncoCyte Corp stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for OncoCyte Corp is critical whether you are bullish or bearish towards OncoCyte Corp at a given time. Please also check how OncoCyte Corp's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in OncoCyte Corp without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Diagnostics Now
Portfolio DiagnosticsUse generated alerts and portfolio events aggregator to diagnose current holdings |
| All Next | Launch Module |
OncoCyte Corp Corporate Management
Elected by the shareholders, the OncoCyte Corp's board of directors comprises two types of representatives: OncoCyte Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of OncoCyte. The board's role is to monitor OncoCyte Corp's management team and ensure that shareholders' interests are well served. OncoCyte Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, OncoCyte Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ekkehard MD | Chief Officer | Profile | |
| Joshua Riggs | Interim Officer | Profile | |
| Tony Kalajian | Senior Vice President Chief Accounting Officer | Profile | |
| Andrew Last | Independent Director | Profile | |
| YuhMin Chiang | Senior Development | Profile |
How to buy OncoCyte Stock?
Before investing in OncoCyte Corp, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in OncoCyte Corp. To buy OncoCyte Corp stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of OncoCyte Corp. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase OncoCyte Corp stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located OncoCyte Corp stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased OncoCyte Corp stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as OncoCyte Corp, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy OncoCyte Stock please use our How to Invest in OncoCyte Corp guide.
Already Invested in OncoCyte Corp?
The danger of trading OncoCyte Corp is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of OncoCyte Corp is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than OncoCyte Corp. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile OncoCyte Corp is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether OncoCyte Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of OncoCyte Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Oncocyte Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Oncocyte Corp Stock: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OncoCyte Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy OncoCyte Stock please use our How to Invest in OncoCyte Corp guide.Note that the OncoCyte Corp information on this page should be used as a complementary analysis to other OncoCyte Corp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Complementary Tools for OncoCyte Stock analysis
When running OncoCyte Corp's price analysis, check to measure OncoCyte Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OncoCyte Corp is operating at the current time. Most of OncoCyte Corp's value examination focuses on studying past and present price action to predict the probability of OncoCyte Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OncoCyte Corp's price. Additionally, you may evaluate how the addition of OncoCyte Corp to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |
Is OncoCyte Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OncoCyte Corp. If investors know OncoCyte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OncoCyte Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.08) | Revenue Per Share 0.168 | Quarterly Revenue Growth (0.41) | Return On Assets (0.18) | Return On Equity (1.32) |
The market value of OncoCyte Corp is measured differently than its book value, which is the value of OncoCyte that is recorded on the company's balance sheet. Investors also form their own opinion of OncoCyte Corp's value that differs from its market value or its book value, called intrinsic value, which is OncoCyte Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OncoCyte Corp's market value can be influenced by many factors that don't directly affect OncoCyte Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OncoCyte Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if OncoCyte Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OncoCyte Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.